hRBP4
Nomenclature
C57BL/6JSmo-Rbp4tm1(hRBP4)Smoc
Cat. NO.
NM-HU-234023
Strain State
Repository Live
Gene Summary
Gene Symbol
Rbp4
Model Description
Validation Data

Fig.1 Detection of RBP4 expression in liver by RT-PCR.
Wild type: only one band at 213 bp with primers F1/R1(mRbp4);
Homozygous: only one band at 233 bp with primers F2/R2(hRBP4).
Abbr. M, DNA marker; HO, homozygous; WT, wild type.

Fig.2 Detection of humanized RBP4 mRNA expression by qPCR.
Relative expression was reported as the percentage to hRBP4 mRNA levels in liver, eyes or kidney of 7-week-old male or 5-week-old female hRBP4 knockin mice, respectively.
Abbr. HO, homozygous; WT, wild type.

Fig.3 Detection of human RBP4 expression in the kidney of HO hRBP4 mice by WB.
The human RBP4 expression detected using a cross-reactive antibody that recognizes both mouse and human RBP4 was quantified by measuring the mean intensity.
Abbr. M, marker; WT, wild type; HO, Homozygous.

Fig.4 Detection of human RBP4 expression in the liver of hRBP4 knockin mice by WB.
The human RBP4 expression was quantified by measuring the mean intensity.
Abbr. M, marker; WT, wild type; HO, Homozygous.

Fig.5 Detection of human RBP4 expression in the eye of hRBP4 knockin mice by WB.
The human RBP4 expression was quantified by measuring the mean intensity.
Abbr. M, marker; WT, wild type; HO, Homozygous.

Fig.6 Detection of human RBP4(A) and mouse RBP4(B) expression in plasma of WT C57BL/6 mice and HO hRBP4 mice by ELISA. Human RBP4 was exclusively detectable in HO hRBP4 mice. Mouse RBP4 was exclusively detectable in WT C57BL/6 mice. Plasma were collected from wild-type C57BL/6 mice (n=3, 6-7 weeks old) and HO hRBP4 mice (n=3, male, 8 weeks old), and analyzed by ELISA.
Abbr. HO, homozygous; WT, wild type; N.D., not detected.
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more